참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | N-bromobutanimide | HCID 67184 | — |
| 반응물 | 3,6,6-Trimethyl-1-pyridin-2-yl-5,7-dihydroindazol-4-one | HCID 4165246 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 생성물 | 7-Bromo-3,6,6-trimethyl-1-pyridin-2-yl-5,7-dihydroindazol-4-one | HCID 4073986 | — |
반응 단계
A mixture of 1-(2-pyridyl)-3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydroindazole (0.25 g, 0.98 mmol), prepared as described in example 3, and N-bromosuccinimide (0.180 g, 0.98 mmol) in chloroform (6 ml) was stirred at 60° C. for about 4 hours and then washed with water. The organic phase was dried over sodium sulfate and evaporated to dryness. The residue was chromatographed on silica gel (cyclohexane:ethyl acetate=90:10). The title compound was obtained as a colourless solid (0.28 g, 85%): m.p 160-161° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US06716856B1 |
|---|
| 출처 데이터셋 | uspto-grants-2004_04 |
|---|
| ORD ID | ord-445e38361a5948df8fe163982b494a9a |
|---|
| 출처 메모 | uspto-grants-2004_04 |
|---|